医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2023年第32届美国临床内分泌学会年会(AACE)
     
 
 

◆ 会议时间:2023年5月4日至6日
◆ 会议地点:美国 西雅图(Seattle, Washington)

 

◆ 会议简介:

2023年第32届美国临床内分泌学会(AACE)年会将于2023年5月3日至6日在美国西雅图举行。AACE年会是临床内分泌学家和其他卫生保健专业人士参与的最重要的会议之一,会议为与会者提供了一个学习交流有关糖尿病、甲状腺功能异常、骨质疏松症、肥胖和其他代谢疾病患者所需的最新研究进展、措施和转化疗法的平台,预计有来自世界各地的3000余名专业人士参会。

美国临床内分泌学会(AACE)成立于1991年,是由专注于内分泌、糖尿病和新陈代谢的医师参与组成的大型专业组织,现在全球90多个国家和地区拥有超过7000名成员。AACE致力于提高其成员为患者提供高质量护理的能力。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com).

AACE 2023 – 32nd Annual Meeting of the American Association of Clinical Endocrinology
May 4–6, 2023
Washington State Convention Center
Seattle, Washington, USA

 

About AACE's Annual Meeting

Each year, experts from the field of endocrinology convene to collaborate, learn and earn CME, CE and MOC through a combination of state-of-the-art-lectures, advanced learning experiences, engaging sessions, expert panel discussions, abstracts and more. This year, AACE is celebrating its 30 years of elevating endocrinology and improving global health!

Who Attends AACE's Annual Meeting?

Attendees are comprised of medical professionals from the field of clinical endocrinology at all stages in their career including clinical endocrinologists, general practitioners, nurse practitioners, nurses, allied health professionals, medical students, residents and fellows in training. With a wide array of educational options and continuing medical education offerings, participants can select to attend the sessions that are most relevant to their practice.

 

摘要征文投稿:

Abstracts accepted September 29 - December 1, 2022

Submit a late breaking abstract for the opportunity to showcase your work to experts in the field of endocrinology. Deadline Friday, March 17, 2023 at 11:59 pm ET

点此提交摘要>>>Submit Abstract>>>

 

ELIGIBILITY REQUIREMENTS 

WHAT IS ELIGIBLE FOR SUBMISSION? 

  • Abstracts may be submitted by AACE community members or Non-Members sponsored by an AACE community member. If you are not a member, you may join online.
  • Abstracts describing original research, clinical trials, or case studies/series related to the area of endocrinology may be submitted. 
  • Abstract submissions must be an original contribution and may not have previously been published or presented at any national/international meeting(s) in the same format at the time of abstract submission. 
  • By submitting your abstract, you agree to present the abstract if it is selected for presentation during the Annual Meeting.  
  • All accepted abstracts will be published as an online supplement to Endocrine Practice
  • If the abstract reports on the results of a clinical trial not yet approved by a regulatory agency, you will be required to identify the trial phase. 
  • Authorship on multiple abstracts is permitted.  

WHAT IS NOT ELIGIBLE FOR SUBMISSION? 

  • The same study should not be submitted as multiple abstracts. Abstracts that appear as more than one version of a single study will be rejected. 
  • Abstracts submitted for the late-breaking category cannot be submitted to another category.  
  • Submitting authors who are not AACE community members or do not have an AACE community member sponsor will not be eligible to submit. 
  • Abstracts that have been previously published or presented at any national/international meeting are not eligible submissions. 

ABSTRACT CATEGORIES 

  • Adrenal Disorders 
  • Diabetes/Prediabetes/Hypoglycemia
  • Education/Quality Improvement  
  • Lipids/Cardiovascular Health 
  • Obesity/Nutrition 
  • Parathyroid/Bone Disorders
  • Pediatric Endocrinology 
  • Pituitary Disorders/Neuroendocrinology 
  • Reproductive & Transgender Endocrinology 
  • Thyroid  
  • Other (genetic syndromes, new innovation, etc)

ABSTRACT FORMAT 

The abstract limit is 2,700 characters, including spaces. Count excludes the title, names of authors/co-authors, authors’ affiliations and disclosures. Abstracts marked “incomplete” at the close of the submission deadline will be ineligible for consideration. 

TITLES 

  • Titles should be brief, clearly indicating the topic category (limited to 250 characters including spaces). 
  • Trial group names should not appear in the title. 
  • Enter the title in the “title” field only and do not enter the title in the body of the abstract. 
  • Author names and affiliations should not appear in the title. 

Correct example: This is a Properly Formatted Abstract Title 

AUTHORS 

  • Submitting authors will be listed as the primary author on the abstract and be the main contact for all correspondence. NO EXCEPTIONS. 
  • Do not list authors or commercial relationships in the body of the abstract. Please consult with your co-authors on how they would like their names to appear prior to the submission of the abstract. 
  • All authors must disclose any relevant financial relationship(s) at the time of abstract submission. There is a limit of 15 authors that may be included in the author block. 

CONTENT 

  • Prior to submitting the abstract, please ensure that it is proofread by an individual who speaks fluent English and can make recommendations as needed. 
  • Preliminary or incomplete data are not allowed.  
  • Do not use new technical words, laboratory slang, words not defined in dictionaries, abbreviations, or terminology not consistent with internationally accepted guidelines. Define any abbreviations the first time they are used. Omit all names and geographical references in the body of the abstract. Organize content as follows: 

Original Research/Clinical Trial  

  • Objective: Background or Statement of Purpose 
  • Methods: Methods, materials and analytical procedures used 
  • Results: Summary of the results in sufficient detail to support conclusion 
  • Discussion/Conclusion: Discuss the content and interpret the data 

Case Study/Case Series  

  • Introduction 
  • Case(s) description 
  • Discussion  

ABBREVIATIONS 

  • Use standard abbreviations. Place abbreviations in parentheses after the first time the full word appears. Do not abbreviate compounds in the title of the abstract. Use numerals to indicate numbers, except when beginning sentences. 

USE OF ACRONYMS 

  • AACE will only publish commonly used acronyms included in the unified list of acronyms approved by the principal journal editors in the field of endocrinology. Please refrain from using all trial group acronyms in abstract titles. Acronyms may remain in the body of the abstract and in the author list. 

TABLES AND GRAPHICS 

  • Tables, images, and/or graphs SHOULD NOT be submitted.  

ABSTRACT PROCESSING FEE 

AACE does not charge a processing fee for abstract submissions.   

COPYRIGHT TRANSFER AGREEMENT 

During submission, the author will be requested to agree to a copyright transfer should the abstract be accepted. The submitting author will agree to the terms of the copyright transfer on behalf of all co-authors. The Agreement transfers to AACE the copyright and all other rights of the material comprising the abstract upon acceptance. The American Association of Clinical Endocrinology, as holder of the copyright on the accepted abstract, reserves all right of reproduction, distribution, performance, display, and the right to create derivative works in both print and digital formats. No patient rights are assigned.  

ABSTRACT NOTIFICATION 

AACE will notify the primary author of the status of their abstract in mid-February 2023. It is the primary author’s responsibility to then notify all co-authors. AACE requests that all interested parties please refrain from directly contacting the AACE offices to obtain information regarding abstract status, notification distribution and/or publication dates. Please check the Annual Meeting website regularly for the most up to date information. The submitting/primary author is the only author who will receive notification from AACE.  

PUBLICATIONS 

All accepted abstracts will be available on the AACE Annual Meeting website. They will be published as a supplement to Endocrine Practice

E-POSTER PRESENTATIONS

E-Poster presentations are given in person at the conference. The term “e-poster” refers to how AACE no longer presents physical posters and instead displays them on a large monitor. There will be several numbered stations with these monitors. Each presenter will be assigned a date and time of presentation and a station, and at the time of their presentation they stand at the station and give their presentation.

ORAL PRESENTATIONS 

A very limited number of abstracts will be selected for Oral Presentation Sessions. Specific details regarding oral presentations will be sent to the primary authors of the selected abstracts. 

 


 

注册费:

PREMIUM MEETING REGISTRATION

Live Meeting & On-Demand Content!

Up to 18.5 CME/CE/MOC On-site & 42 CME/CE/MOC On-Demand

ALL ACCESS Registration Pass Includes:

  • Opening Ceremony & Keynote Presentation
  • Lectureship Plenary Talks
  • Meet-the-Expert Sessions
  • Cased-Based Learning Workshops
  • The Flipped Classroom Experience
  • Post Plenary Speaker Deep Dives
  • Career Advancement Sessions
  • Welcome Block Party
  • DEI&B Interactive Group Think + Reception
  • President's Party – An Evening in Seattle
  • Satellite Symposiums
  • Posters & Oral Abstract Presentations
  • AACE Learning Zone
  • Pre-Meeting Learning Sessions
  • On-Demand Post Event Content

On-demand sessions will be available June 4, 2023 through December 31, 2023 to earn additional CME/CE/MOC credit.

(CME/CE/MOC credit must be claimed by 12/31/23)

 

Registration Type Early Bird
(Register thru 2/17)
Advanced
(Register thru 4/10)
Standard
(Register thru 5/6)
Engaged Member $777 $888 $1,110
Informed Member $1,036 $1,184 $1,480
Non-Member $1,295 $1,480 $1,850
Fellow, Resident, Students
(AACE Membership Required)
$518 $592 $740

 

 

◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1650元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们